{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:49:51Z","timestamp":1795024191844,"version":"4.10.2"},"reference-count":37,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515140179"],"award-info":[{"award-number":["2023A1515140179"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2025,9,25]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It has traditionally been considered that mother-infant ABO incompatibility only causes mild haemolytic disease of the newborn (HDN). However, this view is inconsistent with clinical practice, and large-scale population-based data are lacking to investigate its effects on neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differences in hospitalisation rates and incidence rates of neonatal hyperbilirubinaemia (NHB) and anaemia among 47 679 Chinese liveborn neonates with different mother-infant ABO combinations, differences in the incidence of ABO-incompatible HDN (ABO-HDN) among neonates with O-B versus O-A mother-infant ABO incompatibility, and the contributions of ABO-HDN to the development of NHB and neonatal anaemia were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 47\u2009679 liveborn neonates, neonates with mother-infant ABO incompatibility had higher rates of hospitalisation and incidence of NHB and anaemia. The hierarchy of the risk of mother-infant ABO incompatibility to the neonate was O-B &gt; O-A &gt; non-O-A\/O-B incompatibility. Among neonates with O-B and O-A mother-infant ABO incompatibility, the ABO-HDN incidence rates were 15.27% (513\/3359) and 11.33% (417\/3680), respectively (95%\u2009CI 1.41 (1.23 to 1.62)), and the severe ABO-HDN incidence rates were 2.05% (69\/3359) and 1.14% (42\/3680), respectively (95%\u2009CI 1.82 (1.23 to 2.67)). Among the 7039 neonates with O-A\/O-B mother-infant ABO incompatibility, ABO-HDN was an independent aetiological factor in 41.11% (666\/1620) of the neonates with NHB, 70.27% (52\/74) of the neonates with severe NHB, 42.34% (163\/385) of the neonates with anaemia and 18.28% (17\/93) of the neonates with severe anaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mother-infant ABO incompatibility often leads to severe HDN and is a dominant cause of NHB and neonatal anaemia, leading to significantly higher neonatal hospitalisation rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2024-328079","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:00:22Z","timestamp":1760515222000},"page":"F236-F242","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of mother-infant ABO incompatibility on neonates: a cohort study in the Chinese population"],"prefix":"10.1136","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-9688","authenticated-orcid":false,"given":"Yuanjun","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"},{"name":"Dongguan Key Laboratory for Precision Diagnosis and Blood Management of Immune Hemolytic Diseases, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"},{"name":"Department of Laboratory Medicine, Dongguan Key Clinical Specialist, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6157-255X","authenticated-orcid":false,"given":"Ganping","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"},{"name":"Dongguan Key Laboratory for Precision Diagnosis and Blood Management of Immune Hemolytic Diseases, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6298-7370","authenticated-orcid":false,"given":"Yinglin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"},{"name":"Dongguan Key Laboratory for Precision Diagnosis and Blood Management of Immune Hemolytic Diseases, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-5539","authenticated-orcid":false,"given":"Liangchang","family":"Xiu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-5612","authenticated-orcid":false,"given":"Yanli","family":"Ji","sequence":"additional","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3269-6917","authenticated-orcid":false,"given":"Minxu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9272-1010","authenticated-orcid":false,"given":"Manna","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Maternity, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6163-7419","authenticated-orcid":false,"given":"Xinghe","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Maternity, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2676-269X","authenticated-orcid":false,"given":"Xuejun","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8838-915X","authenticated-orcid":false,"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4985-9820","authenticated-orcid":false,"given":"Jianqun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0810-5285","authenticated-orcid":false,"given":"Shujie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5241-012X","authenticated-orcid":false,"given":"Miaozhen","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3401-207X","authenticated-orcid":false,"given":"Jiajun","family":"Zeng","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4809-8268","authenticated-orcid":false,"given":"Qianquan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8587-4713","authenticated-orcid":false,"given":"Zhongying","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-5353","authenticated-orcid":false,"given":"Yong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"2026042206050606000_111.3.F236.1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"2026042206050606000_111.3.F236.2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmrv.2018.07.002","article-title":"Red Blood Cell Alloimmunization in the Pregnant Patient","volume":"32","author":"Webb","year":"2018","journal-title":"Transfus Med Rev"},{"key":"2026042206050606000_111.3.F236.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2020.10.009"},{"key":"2026042206050606000_111.3.F236.4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bjh.18170","article-title":"International Collaboration for Transfusion Medicine Guidelines (ICTMG). International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn","volume":"198","author":"Lieberman","year":"2022","journal-title":"Br J Haematol"},{"key":"2026042206050606000_111.3.F236.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812103392410"},{"key":"2026042206050606000_111.3.F236.6","doi-asserted-by":"crossref","unstructured":"Zipursky A , Bhutani VK . Rhesus disease: a major public health problem. Lancet 2015;386. doi:10.1016\/S0140-6736(15)61498-2","DOI":"10.1016\/S0140-6736(15)61498-2"},{"key":"2026042206050606000_111.3.F236.7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S2352-4642(18)30071-3","article-title":"Rhesus disease: a global prevention strategy","volume":"2","author":"Zipursky","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2026042206050606000_111.3.F236.8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(09)60651-6","article-title":"Prevention of rhesus haemolytic disease of the fetus and newborn","volume":"373","author":"Franklin","year":"2009","journal-title":"Lancet"},{"key":"2026042206050606000_111.3.F236.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"de Haas","year":"2016","journal-title":"BMJ"},{"key":"2026042206050606000_111.3.F236.10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5694\/mja17.01144","article-title":"Fifty years of RhD immunoglobulin (anti-D) therapy in Australia: celebrating a public health success story","volume":"209","author":"Thyer","year":"2018","journal-title":"Med J Aust"},{"key":"2026042206050606000_111.3.F236.11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00493","article-title":"Pneumococcal Polysaccharide Vaccination Elicits IgG Anti-A\/B Blood Group Antibodies in Healthy Individuals and Patients with Type I Diabetes Mellitus","volume":"7","author":"Wolfram","year":"2016","journal-title":"Front Immunol"},{"key":"2026042206050606000_111.3.F236.12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/vox.13327","article-title":"The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers","volume":"117","author":"Talwar","year":"2022","journal-title":"Vox Sang"},{"key":"2026042206050606000_111.3.F236.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"2026042206050606000_111.3.F236.14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/2046905512Y.0000000002","article-title":"Morbidity of ABO haemolytic disease in the newborn","volume":"32","author":"Bhat","year":"2012","journal-title":"Paediatr Int Child Health"},{"key":"2026042206050606000_111.3.F236.15","doi-asserted-by":"crossref","DOI":"10.1111\/j.1423-0410.1995.tb02569.x","article-title":"ABO hemolytic disease of the newborn is more severe in Taiwan than in white populations","volume":"68","author":"Lin","year":"1995","journal-title":"Vox Sang"},{"key":"2026042206050606000_111.3.F236.16","first-page":"181","article-title":"Prevalence of ABO maternal-infant incompatibility in Asians, Blacks, Hispanics and Caucasians","volume":"54","author":"Toy","year":"1988","journal-title":"Vox Sang"},{"key":"2026042206050606000_111.3.F236.17","doi-asserted-by":"crossref","unstructured":"Xu W , Jing Z , Qiao X , et al . Survey of the incidence of ABO haemolytic disease of the newborn in one institution in northern China. Authorea 2022.","DOI":"10.22541\/au.164864901.11218237\/v1"},{"key":"2026042206050606000_111.3.F236.18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.114.1.297"},{"key":"2026042206050606000_111.3.F236.19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0329"},{"key":"2026042206050606000_111.3.F236.20","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2012.71"},{"key":"2026042206050606000_111.3.F236.21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2352-4642(18)30139-1","article-title":"Neonatal hyperbilirubinaemia: a global perspective","volume":"2","author":"Olusanya","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2026042206050606000_111.3.F236.22","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S2352-3026(24)00030-9","article-title":"Haemoglobin thresholds to define anaemia from age 6 months to 65 years: estimates from international data sources","volume":"11","author":"Braat","year":"2024","journal-title":"Lancet Haematol"},{"key":"2026042206050606000_111.3.F236.23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.siny.2015.12.001","article-title":"Anemia and transfusion in the neonate","volume":"21","author":"Colombatti","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"2026042206050606000_111.3.F236.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04815.x"},{"key":"2026042206050606000_111.3.F236.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020248"},{"key":"2026042206050606000_111.3.F236.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10690"},{"key":"2026042206050606000_111.3.F236.27","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0444-RS"},{"key":"2026042206050606000_111.3.F236.28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/tme.12512","article-title":"Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years","volume":"29","author":"Matteocci","year":"2019","journal-title":"Transfus Med"},{"key":"2026042206050606000_111.3.F236.29","unstructured":"Working Party on Immunohematology in Chinese Society of Blood Transfusion. Expert consensus on laboratory testing for fetal neonatal hemolytic disease. J Clin Transfus Lab Med 2021;20\u20133."},{"key":"2026042206050606000_111.3.F236.30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41372-018-0048-4","article-title":"ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program","volume":"38","author":"Christensen","year":"2018","journal-title":"J Perinatol"},{"key":"2026042206050606000_111.3.F236.31","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41390-021-01692-3","article-title":"Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US Database","volume":"91","author":"Qattea","year":"2022","journal-title":"Pediatr Res"},{"key":"2026042206050606000_111.3.F236.32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12519-021-00422-3","article-title":"Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China","volume":"17","author":"Dong","year":"2021","journal-title":"World J Pediatr"},{"key":"2026042206050606000_111.3.F236.33","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1651-2227.2009.01478.x","article-title":"Maternal IgG anti\u2010A and anti\u2010B titres predict outcome in ABO\u2010incompatibility in the neonate","volume":"98","author":"Bakkeheim","year":"2009","journal-title":"Acta Paediatr"},{"key":"2026042206050606000_111.3.F236.34","first-page":"506","article-title":"Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter","volume":"55","author":"Akg\u00fcl","year":"2013","journal-title":"Turk J Pediatr"},{"key":"2026042206050606000_111.3.F236.35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/vox.13420","article-title":"Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn","volume":"118","author":"Krog","year":"2023","journal-title":"Vox Sang"},{"key":"2026042206050606000_111.3.F236.36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","article-title":"The ABO blood group system revisited: a review and update","volume":"25","author":"Storry","year":"2009","journal-title":"Immunohematology"},{"key":"2026042206050606000_111.3.F236.37","unstructured":"GnomAD. Genome Aggregation Database . The broad institute. 2023. Available: https:\/\/gnomad.broad institute.org\/"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2024-328079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:06:02Z","timestamp":1776863162000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2024-328079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/archdischild-2024-328079"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2024-328079","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}